Symbol
2seventy bio, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$4.96
Current price of the stock
$454K
Trading volume of the stock
$259.2M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
3.00
Mean analyst rating
10.89%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
4.95
Current ratio
57.38%
Gross profit margin
-103.01%
Operating profit margin
-103.01%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-73.39%
Pretax profit margin
-73.39%
Net profit margin
-4.35%
Measures profitability relative to shareholders' equity
-4.47%
ROE excluding intangible assets
-1.97%
Measures profitability relative to total assets
-4.35%
Measures profitability relative to invested capital
0.03
Asset turnover ratio
-
Inventory turnover ratio
0.61
Receivables turnover ratio
148.13
Average number of days it takes to collect receivables
-2.67
Measures valuation relative to earnings
-
P/E based on future earnings estimates
5.68
Measures valuation relative to sales
1.12
Measures valuation relative to book value
-0.73
Measures valuation relative to operating cash flow
-0.70
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
